Nanomedicine-Mediated Therapies to Target Cancer Stem Cells: An Emerging Technology

Area of Science:

• Oncology
• Nanotechnology
• Biotechnology

Background:

• Cancer stem cells (CSCs) possess self-renewal and differentiation capabilities, contributing to tumor metastasis and recurrence.
• CSCs evade immune surveillance, posing a challenge for conventional cancer treatments.
• Targeting CSCs is crucial for developing more effective cancer therapies.

Purpose of the Study:

• To review recent advancements in cancer therapy utilizing nanotechnology to target cancer stem cells.
• To explore the potential of nanotechnology in eradicating cancer by simultaneously targeting cancer cells and CSCs.

Main Methods:

• Review of current research on nanotechnology applications in cancer therapy.
• Focus on studies targeting CSCs in lung, breast, colorectal, and prostate cancers.

Main Results:

• Nanotechnology enables the development of targeted therapies against CSCs.
• Simultaneous targeting of cancer cells and CSCs with nanoparticles shows potential for improved therapeutic interventions.
• Recent achievements demonstrate progress in applying nanotechnology for CSC-targeted cancer treatment.

Conclusions:

• Targeting cancer stem cells with nanotechnology represents a promising strategy for enhancing cancer treatment efficacy.
• Nanotechnology-based approaches offer a personalized treatment strategy for various malignancies.
• Further research in cancer nanotechnology is essential for developing novel therapeutic interventions against cancer recurrence and metastasis.